Nurse Practitioner, Family · San Diego, CA
NPI
1689307167
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5353 Mission Center Rd Ste 300
San Diego, CA, 92108
Phone (619) 718-9655
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$345K
2,945 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Victoria D Loo prescribed most often to Medicare patients was Atorvastatin Calcium, with 210 prescriptions and refills. In total Victoria D Loo wrote 2,945 Medicare prescriptions that cost $345K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-04.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 210 | 210 | 19 | $11K |
| Amlodipine Besylate Generic | 180 | 181 | 19 | $4,113 |
| Lisinopril Generic | 143 | 143 | 14 | $2,447 |
| Levothyroxine Sodium Generic | 72 | 72 | Under 11 | $1,325 |
| Famotidine Generic | 70 | 70 | Under 11 | $1,771 |
| Metoprolol Succinate Generic | 66 | 66 | Under 11 | $1,016 |
| Tamsulosin Hcl Generic | 62 | 62 | Under 11 | $2,932 |
| Carvedilol Generic | 58 | 58 | Under 11 | $2,457 |
| Furosemide Generic | 57 | 57 | 11 | $570 |
| Donepezil Hcl Generic | 55 | 55 | Under 11 | $3,732 |
| Omeprazole Generic | 55 | 55 | Under 11 | $2,860 |
| Gabapentin Generic | 49 | 49 | Under 11 | $815 |
| Quetiapine Fumarate Generic | 48 | 48 | Under 11 | $2,689 |
| Metformin Hcl Generic | 47 | 47 | Under 11 | $1,171 |
| Hydrochlorothiazide Generic | 44 | 44 | Under 11 | $383 |
Brand drugs: - claims; generic drugs: 2,423 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Victoria D Loo were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.